CAS 54824-17-8|1H-Benz[de]isoquinoline-1,3(2H)-dione,2-[2-(dimethylamino)ethyl]-5-nitro-

Introduction:Basic information about CAS 54824-17-8|1H-Benz[de]isoquinoline-1,3(2H)-dione,2-[2-(dimethylamino)ethyl]-5-nitro-, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common Name1H-Benz[de]isoquinoline-1,3(2H)-dione,2-[2-(dimethylamino)ethyl]-5-nitro-
CAS Number54824-17-8Molecular Weight313.30800
Density1.384g/cm3Boiling Point496.8ºC at 760 mmHg
Molecular FormulaC16H15N3O4Melting Point/
MSDS/Flash Point254.3ºC

Names

Name2-[2-(dimethylamino)ethyl]-5-nitrobenzo[de]isoquinoline-1,3-dione
SynonymMore Synonyms

BiologicalActivity

DescriptionMitonafide (NSC 300288) is a cytostatic agent. Mitonafide binds to double-stranded DNA through intercalation, and inhibits DNA and RNA synthesis. Mitonafide is an antitumor agent that can be used in the research of cancers, such as non-small cell lung cancer (NSCLC), leukemia[1][2][3].
Related CatalogResearch Areas >>CancerSignaling Pathways >>Cell Cycle/DNA Damage >>DNA/RNA Synthesis
Target

DNA and RNA synthesis[1]

In VitroMitonafide inhibits DNA and RNA synthesis and induces single-strand breaks in the DNA of chinese hamster ovary cells[1]. The incubation of Mitonafide with rat liver microsomes and NADPH under anaerobic conditions results in the formation of a metabolite identified as 5-aminomitonafide[2]. Mitonafide (25, 50 μM, 1 h) induces single-stand breaks in the DNA of L1210 cells[2]. Mitonafide (10-100 μM) exhibits cytotoxic effect in the HOP-62 lung cell line[4]. Cell Viability Assay[6] Cell Line: SK-OV-3, HepG2, A-549, T-24, SMMC-7721, HL-7702 Concentration: 0-100 μM respectively. Incubation Time: 48 h Result: Inhibited cell viability with IC50 values of 6.26, 10.88, 7.94, 5.01, 6.94, 8.51 μM.
In VivoMitonafide (0.5 and 1 mg/kg, i.p., 1-7 days) shows antitumoral potency in S-180 bearing mice[4]. Mitonafide (5 mg/kg, i.p., twice a day) shows anticancer activity in HepG2 xenograft model[6]. Mitonafide (single i.p. injection, S-180 bearing mice) shows the LD50 value of 10.0 mg/kg[5]. Animal Model: S-180 bearing mice[4] Dosage: 0.5 mg/kg and 1 mg/kg Administration: Intraperitoneal injection (i.p.) for 1-7 days Result: Increased in median survival times. Animal Model: HepG2 xenograft model [6] Dosage: 5 mg/kg Administration: Intraperitoneal injection (i.p.), twice a day. Result: Exhibited a relative tumor increment rates (T/C) value of 28.8%.
References

[1]. Llombart M, et al. Phase I study of mitonafide in solid tumors. Invest New Drugs. 1992 Aug;10(3):177-81.  

[2]. inha BK, et al. Mechanism of DNA strand breaks by mitonafide, an imide derivative of 3-nitro-1,8-naphthalic acid. Biochem Pharmacol. 1985 Nov 1;34(21):3845-52.  

[3]. Rosell R, et al. Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancer. Invest New Drugs. 1992 Aug;10(3):171-5.  

[4]. Samanta S, et al. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent. J Exp Ther Oncol. 2005;5(1):15-22.  

[5]. Pain A, et al. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent. J Exp Clin Cancer Res. 2003 Sep;22(3):411-8.  

[6]. Xin M, et al. Design, synthesis and biological evaluation of 3-nitro-1,8-naphthalimides as potential antitumor agents. Bioorg Med Chem Lett. 2020 Apr 15;30(8):127051.  

Chemical & Physical Properties

Density1.384g/cm3
Boiling Point496.8ºC at 760 mmHg
Molecular FormulaC16H15N3O4
Molecular Weight313.30800
Flash Point254.3ºC
Exact Mass313.10600
PSA88.13000
LogP1.94570
Index of Refraction1.667
InChIKeyXXVLKDRPHSFIIB-UHFFFAOYSA-N
SMILESCN(C)CCN1C(=O)c2cccc3cc([N+](=O)[O-])cc(c23)C1=O
Storage condition2-8°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QK5650000
CHEMICAL NAME :
Naphthalimide, 2-(2-(dimethylamino)ethyl)-5-nitro-
CAS REGISTRY NUMBER :
54824-17-8
LAST UPDATED :
199612
DATA ITEMS CITED :
6
MOLECULAR FORMULA :
C16-H15-N3-O4
MOLECULAR WEIGHT :
313.34
WISWESSER LINE NOTATION :
T666 1A M CVNVJ D2N1&1 HNW

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
6500 ug/kg
TOXIC EFFECTS :
Tumorigenic - active as anti-cancer agent
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
10000 ug/kg
TOXIC EFFECTS :
Tumorigenic - active as anti-cancer agent

MUTATION DATA

TYPE OF TEST :
Mutation test systems - not otherwise specified
TEST SYSTEM :
Rodent - mouse Ascites tumor
DOSE/DURATION :
4 mg/L
REFERENCE :
CCPHDZ Cancer Chemotherapy and Pharmacology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1978- Volume(issue)/page/year: 4,61,1980

Safety Information

HS Code2933990090

Customs

HS Code2933990090
Summary2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Synonyms

2-(2-(dimethylamino)ethyl)-3-nitro-1H-benzo[de]isoquinoline-1,3(2H)-dione
Mitonafidum [INN-Latin]
Mitonafida [INN-Spanish]
M 4212 (Pharmaceutical)
2-(2-(dimethylamino) ethyl)-5-nitro-1H-benzo[de]isoquinoline-1,3(2H)-dione
N-(2-(Dimethylamino)ethyl)-3-nitronaphthalimide
M-4212
2-(2-dimethylaminoethyl)-5-nitrobenzo[de]isoquinoline-1,3-dione
Mitonafide
CAS 662117-63-7|2-Amino-5-chloro-4-methoxypyridine
CAS 54824-20-3|1H-Benz[de]isoquinoline-1,3(2H)-dione,5-nitro-2-[2-(1-pyrrolidinyl)ethyl]-
Recommended......
TOP